Mycobacterium smegmatis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 18: Line 18:
==Treatment==
==Treatment==
===Antimicrobial regimen===
===Antimicrobial regimen===
* in vitro
:* susceptible: [[Sulfonamides]], [[Doxycycline]], [[Imipenem]], and [[Amikacin]]
* Mild disease
:* Preferred regimen: [[Doxycycline]] {{and}} [[Trimethoprim–sulfamethoxazol]] orally
* Severe disease
:* Preferred regimen: [[Amikacin]] {{or}} [[Imipenem]] IV


==References==
==References==

Revision as of 15:16, 7 July 2015

Mycobacterium smegmatis

Scientific classification
Kingdom: Bacteria
Phylum: Actinobacteria
Order: Actinomycetales
Family: Mycobacteriaceae
Genus: Mycobacterium
Species: M. smegmatis
Binomial name
Mycobacterium smegmatis
(Trevisan 1889)
Lehmann & Neumann 1899

Mycobacterium smegmatis is an acid-fast bacterial species in the genus Mycobacterium. It was first reported in November 1884 by Lustgarten who found a bacillus with the staining appearance of tubercle bacilli in syphilitic chancres. Subsequently, Alvarez and Tavel found organisms similar to that described by Lustgarten as well as in normal genital secretions (smegma). This organism was later named M. smegmatis.

M. smegmatis is generally considered a non-pathogenic microorganism, however in some cases it can cause disease, mainly in animals.

Treatment

Antimicrobial regimen

  • in vitro
  • Mild disease
  • Severe disease

References

External links

Template:Bacteria-stub